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PURPOSE IN LIFE IN ALS PATIENT-CAREGIVER DYADS: A MULTILEVEL 
LONGITUDINAL ANALYSIS 
 
 
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease. 
Despite the debilitating nature of this disease, some evidence suggests patients maintain 
their quality of life (QOL). Caregivers, on the other hand, experience decreased QOL. 
Evidence suggests existential aspects of well-being such as purpose in life (PIL) may be 
unique and stable sources of well-being for patients and caregivers. Furthermore, 
patients’ and caregivers’ well-being may impact one another. The present study examined 
the variance structure, trajectory, and dyadic relationship of PIL and QOL in patients with 
ALS and their caregivers (N = 110 dyads). Data from the Seattle ALS Patient Profile 
Project were utilized; PIL and QOL were assessed seven times, over eighteen months. 
PIL was more stable than QOL and therefore a psychological resource for patients and 
caregivers. PIL and QOL declined with time and disease severity. Individual differences 
in proximity to diagnosis and death moderated within-individual change. Decline was 
more rapid following diagnosis and approaching death, suggesting these are critical 
periods in which individuals need increased support. Well-being within the dyad was 
interrelated. Average QOL was similar across dyads. PIL within the dyad changed 
together over time. Dyadic relationships may reflect similar life conditions and a shared 
disease experience. 
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Chapter One: Introduction 
Terminal illness is accompanied by emotional distress, including depression and 
hopelessness, for some individuals. Other individuals are able to maintain their 
psychological well-being following a terminal diagnosis (Block, 2001). Existential 
aspects, including purpose in life (PIL), may be a source of resiliency in patients. 
Caregivers may also derive a sense of purpose in their role. Maintaining PIL potentially 
benefits patients’ and caregivers’ physical and psychological health. Patients with 
Amyotrophic Lateral Sclerosis (ALS) in particular have exhibited resiliency, including 
sustained quality of life, despite disease progression (Neudert, Wasner, & Borasio, 2004; 
Robbins, Simmons, Bremer, Walsh, & Fischer, 2001; Simmons, Bremer, Robbins, 
Walsh, & Fischer, 2000). In contrast, caregivers to these patients experience decline in 
their overall quality of life as the patient becomes progressively more ill (Roach, Averill, 
Segerstrom, & Kasarskis, 2009). Evidence suggests that patients’ existential quality of 
life impacts aspects of psychological well-being in their caregivers (Pagnini et al., 2011). 
However, little is known about how PIL shifts within the dyad over the patient’s disease 
course. The present study examined the variance structure, trajectory, and dyadic 
relationship of PIL in patients with ALS and their caregivers. The trajectory of quality of 
life (QOL) was also examined to replicate and extend previous research. 
Amyotrophic Lateral Sclerosis 
ALS is a progressive neurodegenerative disease with cardinal features including 
upper and lower motor neuron degeneration appearing in multiple regions of the body 
and leading to muscle weakness and wasting (Chaudhuri et al., 1995). Challenges 
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associated with ALS include a rapid progression rate with a median survival of 4 years 
(Ringel et al., 1993), an unknown disease cause, a single available treatment option, and 
no cure. The disease course is heterogeneous with differing sites of onset and progression 
rates among patients (Ringel et al., 1993).  
Over time, patients with ALS require increased care as their disease progresses. 
Many of these care providers are family members. Caregivers of patients with ALS face 
multiple challenges, often including leaving the workforce, physical demands as the 
patients’ illness progresses, and, for spousal caregivers, nearing widowhood. Ultimately, 
caregivers will take over responsibilities including managing the household, patient 
hygiene, and implementing the multidisciplinary care needs of the patient. The challenges 
associated with ALS patients’ physical decline for caregivers may not only reflect an 
increasing caregiver load but also grieving the patients’ loss of physical ability over time 
(Rhoades & McFarland, 1999).  
Well-being Measures 
Maintaining well-being is a salient goal in providing care to patients with ALS 
and their caregivers. Well-being can be characterized by a variety of constructs including 
QOL and PIL. QOL reflects multidimensional aspects of objective (e.g., measurable life 
conditions and circumstances) and subjective (e.g., personal satisfaction) well-being 
(Felce & Perry, 1995). Due to its multidimensional nature, consensus on the definition of 
QOL is unresolved. QOL generally involves a combination of life conditions, satisfaction 
with these conditions, and appraisal of the importance of such conditions in one’s life 
(Felce & Perry, 1995). QOL is comprised of several domains, which may include 
physical, material, social, developmental, and/or emotional well-being. The emotional 
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well-being aspect of QOL may relate primarily to hedonic factors (e.g., positive affect 
and satisfaction) but may also include eudemonic factors (e.g., fulfillment and spiritual 
well-being). Notably, individuals may weigh the importance of QOL domains differently 
(e.g., one person highly valuing emotional well-being, and another highly valuing 
physical well-being). Individual perception is a critical aspect of QOL, though measures 
infrequently account for the subjective appraisal of domain importance.  
PIL is a more concise construct focused on existential well-being and eudemonia 
independent of adversity (Ryff, Singer, & Love, 2004). Frankl’s experience as a 
Holocaust concentration camp prisoner inspired his writings about finding meaning in 
life through extreme hardships, including the loss of his family and physical suffering 
(Frankl, 1963; Frankl, 1967). These writings have influenced the development of the 
psychological constructs PIL and meaning in life. Crumbaugh and Maholick (1964) 
defined PIL as “the ontological significance of life from the point of view of the 
experiencing individual” (p. 201). Reker and Wong (1988) defined meaning in life as 
“the cognizance of order, coherence, and purpose in one’s existence, the pursuit and 
attainment of worthwhile goals, and an accompanying sense of fulfillment” (p. 221). 
Meaning in life has been proposed to have cognitive, motivational, emotional, relational, 
and personal components (Maddi, 1967; Reker & Wong, 1988; Wong, 1998). Several 
PIL and meaning in life measures exist. The Purpose in Life Test has demonstrated 
strong concurrent validity with other meaning in life measures including the Frankl 
Questionnaire, the Life Regard Index, the Sense of Coherence Scale, the Meaningful Life 
Measure, the Meaning in Life Questionnaire, and the Scales of Psychological Well-Being 
Purpose in Life subscale (Crumbaugh & Maholick, 1964; Crumbaugh & Maholick, 1969; 
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Debats, 1990; McDonald, Wong, & Gingras, 2012; Morgan & Farsides, 2009; Ryff 1989; 
Steger, Frazier, Oishi, & Kaler, 2006; Zika & Chamberlain, 1992). For clarity, “PIL” will 
be used henceforth to refer to the overlapping meaning in life and PIL constructs.  
Purpose in Life Health Relevance 
PIL measures associate with positive psychological indices (e.g., mood and 
happiness) as well as markers of better physical health spanning from biomarkers (e.g., 
cardiovascular and immune) to decreased risk of premature mortality (Boehm & 
Kubzansky, 2012; Boyle, Barnes, Buchman, & Bennett, 2009; Friedman, Hayney, Love, 
Singer, & Ryff, 2007; Matthews, Owens, Edmundowicz, Lee, & Kuller, 2006; Ryff, 
1989; Ryff & Keyes, 1995; Ryff, Lee, Essex, & Schmutte, 1994; Ryff et al., 2004; 
Westerhof, Bohlmeijer, Beljouw, & Pot, 2010; Zika & Chamberlain, 1992). Positive 
psychological elements, including PIL, may also reduce the burden of illness in older 
adults (Boyle et al., 2009). The Rush Memory and Aging Project discovered that PIL 
attenuated the relationship between physical brain pathology and longitudinal measures 
of cognitive ability in patients with Alzheimer’s disease (Boyle, Buchman, Wilson, Yu, 
Schneider, & Bennett, 2012). Psychological factors have also been associated with longer 
disease survival in ALS (Johnston et al., 1999; McDonald, Wiedenfeld, Hillel, Carpenter, 
& Walter, 1994). 
Well-being in Patients with ALS and Caregivers 
Despite physical impairments, patients with ALS have generally been shown to be 
psychologically resilient. Evidence suggests that rates of clinical depression in patients 
with ALS are low (Averill, Kasarskis, & Segerstrom, 2007; McDonald et al., 1994; 
McDonald, Hillel, & Wiedenfeld, 1996; Rabkin, Wagner, & Del Bene, 2000). In contrast, 
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other research has reported elevated distress including depression and anxiety levels 
similar to psychiatric outpatients (Felgoise et al., 2010). Existential themes among 
patients coping with ALS may give insight into psychological resiliency (Bello-Haas et 
al., 2000; Fegg et al., 2010; Ozanne, Graneheim, & Strang, 2013; Pagnini et al., 2011; 
Young & McNicoll, 1998). For example, individuals with ALS who were hand-picked in 
a qualitative study as exceptionally adapted to the disease “developed an enhanced 
philosophical perspective on life as a result of living with ALS” (p. 39; Young & 
McNicoll, 1998). In patients with ALS, spiritual well-being, specifically in religious 
context, positively relates to better psychological, social, and physical health status 
ratings on the Sickness Impact Profile (Bello-Haas et al., 2000).   
For caregivers, research also suggests that despite losses and perceived burden, 
some individuals are able to find meaning in their role (Noonan & Tennstedt, 1997; 
Rabkin et al., 2000; Rhoades & McFarland, 1999). There is also evidence that individuals 
who experience lower levels of meaning in caregiving may be more likely to experience 
depressive symptoms (Noonan & Tennstedt, 1997). 
Previous research utilizing QOL as a measure of well-being in patients with ALS 
has found similar results indicative of patient resiliency. In one sample, patient general 
QOL did not significantly decline across a 6-month period and no relationship was found 
with disease severity (Robbins et al., 2001). In another sample, patient QOL did not 
significantly decrease over a 5-month period, though a significant relationship was found 
with disease severity (Rabkin et al., 2000). Additionally, patients with ALS followed up 
to 5 years were able to maintain their QOL as their disease progressed (Roach et al., 
2009). Conversely, it appears caregivers’ psychological well-being may be more 
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impacted by patient disease severity; caregivers’ total QOL declined significantly over 
this 5-year period (Roach et al., 2009). Notably, caregiver ratings on the QOL Existential 
subscale were more stable than their total or single-item QOL score (Roach et al., 2009), 
suggesting existential QOL is distinct from overall and self-assessed QOL in caregivers.  
Dyadic Relationships 
A reciprocal relationship between patient and caregiver distress has been reported 
(Rabkin et al., 2000). In patients with ALS, existential QOL was positively associated 
with their caregiver’s self-assessed QOL and existential QOL and negatively associated 
with their caregiver’s ratings of depression, anxiety, and caregiver burden (Pagnini et al., 
2011). Similarly, in patients with cancer and their caregivers, spiritual well-being was 
positively associated with the dyad partner’s physical health component of QOL (Kim, 
Carver, Spillers, Crammer, & Zhou, 2011). Therefore, it is plausible that although 
caregivers may face declines in QOL, some caregivers may be able to adapt by 
developing PIL over time, which may in turn be influenced by the patient’s perceptions 
of his or her own PIL. 
Stability and Variability in Purpose in Life 
It is unclear whether PIL is a stable trait. Some have suggested that PIL is fairly 
stable (Reker, Peacock, & Wong, 1987), yet others have suggested changes in PIL occur 
through various life stages (Lazarus & DeLongis,1983; Pinquart, 2002; Yalom, 1980). 
Moreover, an individual may derive a sense of purpose from a variety of sources 
including religion or spirituality, career or volunteer experiences, education, personal 
roles, values, feelings of usefulness, competency, interpersonal relationships, lifetime 
achievements, and life experiences (Pinquart, 2002; Reker et al., 1987) which may 
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change over both short periods of time and longer developmental periods (e.g., over the 
lifespan; Yalom, 1980). Therefore, one’s source of purpose may result from past 
experiences as well as current activities. Loss of sources an individual previously relied 
on for PIL has been suggested to account for age-related changes found in PIL (Pinquart, 
2002).  
Diagnosis and death are two critical yet distinct points in the lives of both patients 
and caregivers. Receiving a fatal diagnosis may alter the life course, provoking 
individuals to reframe their life, its quality, and their sources of purpose. This event may 
also change the caregivers’ life course, as caregivers often leave the workforce once 
patients’ illness becomes severe. Additionally, as the patient approaches death, existential 
distress or acceptance may cause variance in well-being. Both patients and caregivers 
may experience a sense of loss, including autonomy and the eventual death of the patient. 
Caregiver responsibilities also increase as the patient becomes paralyzed. Therefore, 
variance in PIL and QOL may be explained by time since patient diagnosis or time to 
death.  
Psychological well-being can be characterized both by its mean across time and 
its variability, which may have distinct consequences. Variance structure provides insight 
into differences between people or changes within an individual. Within-individual 
change over time is also termed intraindividual variability (IIV). Time-structured and net 
IIV are two kinds of within-individual change: time-structured IIV is variance that is 
systematically structured in relation to time, and net IIV is variance that is unstructured in 
relation to time (Ram & Gerstorf, 2009). Examining variance characteristics allows for 
better understanding of psychological phenomena in regard to context including dynamic 
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characteristics and processes (Ram & Gerstorf, 2009). Mean levels and IIV can both 
predict later health (Boehm, Winning, Segerstrom, & Kubzansky, in press). 
Variance structure can provide insight to changes in well-being in the context of 
progressive diseases including ALS. Previous research in patients with ALS and their 
caregivers reported greater within-person variability in overall QOL than existential 
QOL. Patient within-individual change reflected net IIV, in which overall QOL was 
unstructured with regard to time. Caregiver within-individual change reflected time-
structured IIV, in which overall QOL decreased systematically with the passage of time 
(Roach et al., 2009). Applying IIV methods to the measure of PIL may aid in clarification 
of the nature of the stability of the construct as well as the sources of variance in patients 
and caregivers.  
The Current Study 
PIL may provide insight into resiliency in both patients and their caregivers, 
despite potential declines in caregiver QOL. The current study examined the variance 
structure, trajectory, and dyadic relationship of PIL in patients with ALS and their 
caregivers. Additionally, this study evaluated the trajectory of PIL in comparison to QOL 
in these two samples. These analyses give insight to well-being patterns in patients with 
ALS and their caregivers as well as provide clarity regarding PIL stability, a clinically 
relevant measure of psychological health. The current study aims were threefold:  
Aim1: Examine the variance structure and trajectory of PIL in patients with ALS 
and their caregivers. 
 9 
Hypothesis 1a:  A greater portion of patient and caregiver variability in 
PIL will be due to differences between individuals than variability within 
the individual, reflecting greater within-person stability. 
Hypothesis 1b: Neither patient nor caregiver PIL will be significantly 
systematically related to time since diagnosis.  
Aim 2: Examine the variance structure and trajectory of QOL in patients with 
ALS and their caregivers 
Hypothesis 2a: QOL will exhibit greater within-person variability than 
PIL, as indicated by the intraclass correlation coefficients, and consistent 
with previous research examining existential QOL (Roach et al., 2009). 
Hypothesis 2b: Patient QOL will not be significantly systematically 
related to time since diagnosis.  
Hypothesis 2c: Caregiver QOL will systematically decrease over time 
since patient diagnosis, replicating previous research (Roach et al., 2009). 
Aim 3: Examine the relationship between patient and caregiver mean and 
intraindividual variability of PIL and QOL.  
Hypothesis 3a: Patient-caregiver mean PIL will significantly covary 
within dyads. 
Hypothesis 3b: Patient and caregiver PIL IIV will fluctuate together over 
time. 
Hypothesis 3c: Patient-caregiver mean QOL will significantly covary 
within dyads. 
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Hypothesis 3d: Patient and caregiver QOL IIV will not fluctuate together 
over time.   
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Chapter Two: Methods 
Participants 
An archival sample of 130 patients with ALS (86 men, 44 women) and 110 
caregivers (31 men, 79 women) was utilized in the current study (see Table 1 for 
demographics, disease characteristics, and baseline scores). Participants were recruited 
through the Seattle ALS Patient Profile Project. The patient sample consisted of adults 
aged 18 years or older who met inclusion criteria (i.e., a confirmed ALS diagnosis by a 
neurologist, and absence of dementia or alcoholism). The average age of the patient 
sample was 61 years at study entry (SD = 11 years) with a range of 33-82. Self-reported 
race of the patient sample was 94.6% white, 3.6% African American, 0.8% Hispanic, and 
0.8% Native American. The average patient age at diagnosis was 57 years (SD = 12 
years). The majority of patients’ disease onset was in the limbs, 82.3% (n = 107). A wide 
range of patient physical function was included in the sample: 16 subjects (12.3%) were 
on a respirator, and 13 patients (10%) had a feeding tube at baseline. Of those using 
respirators at baseline, 18.75% (n = 3) used a respirator less than 8 hours per day, 6.25% 
(n = 1) used a respirator 8-15 hours per day, and 75% (n = 12) used a respirator 20-24 
hours per day. The average ALS Severity Scale score was 24.32 (SD = 8.55) at study 
enrollment, reflecting moderate disease severity. 
The average age of the caregiver sample at study entry was 57 years (SD = 14 
years.) with a range of 19-79. Self-reported race of the caregiver sample was 93.6% 
white, 4.5% African American, 0.9% Asian, and 0.9% Native American.  The majority of 
caregivers were spouses or significant others of the patient, 85.5% (n = 94); however, 
other relatives, 14.5% (n = 16), were also included in the sample.  
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The current study involved several model comparisons. Inequality in number of 
observations across models prevents direct comparison of fit statistics. Therefore, data 
from 10 dyads were excluded for missing diagnosis or date of death values. One 
additional caregiver was excluded from the sample for having a non-relative relationship 
to the patient (e.g., paid caregiver or friend), qualitatively different from relative 
caregivers. Three patient-caregiver dyads were also excluded as outliers due to 
enrollment greater than 20 years from diagnosis.  
Design and Procedures 
Data were collected by the Seattle ALS Patient Profile Project. This project 
commenced in 1986, and the last study visit occurred in 1989. Subjects were recruited 
from the ALS and Neuromuscular Research Foundation of San Francisco, the ALS 
Health Support Services of Seattle, and the ALS Clinic of Hahnemann University 
Philadelphia. The study was IRB approved at all three institutions, and all participants 
signed informed consent at their respective institution. Participants were interviewed at 
their residences by trained staff. Interviews occurred in 7 waves, repeated approximately 
every 3 months, over the course of 18 months for each subject. At baseline, participants 
completed forms including demographic information, medical history, patient disease 
severity, and a questionnaire battery including psychosocial measures. Psychosocial and 
disease severity measures were repeated at each successive wave. See McDonald and 
colleagues (1994) for further methodological details. 
Measures 
Purpose in Life Test. The Purpose in Life Test is a 20-item scale that assesses the 
degree to which an individual has found meaning and purpose in his or her life (e.g., “My 
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personal existence is very purposeful and meaningful” and “If I should die today, I would 
feel that my life has been worthwhile”) (Crumbaugh & Maholick, 1969). Items are rated 
on a 7-point scale. The measure provides a single score ranging from 20-140 in which 
scores greater than 112 reflect definite purpose, scores of 92-112 reflect an indecisive 
level, and scores below 92 reflect a lack of clear meaning and purpose. The Spearman-
Brown split-half reliability of PIL was .87 among a sample of University students 
(Crumbaugh & Maholick, 1964) and .92 among a sample of Protestant parishioners 
(Crumbaugh, 1968). Additionally, test-retest reliability over six weeks was .79 among the 
student sample (Crumbaugh & Maholick, 1964).  
Discriminant validity of PIL has been examined with regard to other measures of 
psychological well-being and depression (Zika & Chamberlain, 1992; Boyle et al., 2009; 
Ryff et al., 2004). The Purpose in Life Test has been found to have a moderate negative 
correlation with the MMPI Depression scale (Crumbaugh & Maholick, 1964). Evidence 
for discriminant validity comes from a higher correlation between PIL and religiosity 
than between psychological well-being and religiosity (Chamberlain & Zika, 1992), and a 
significant relationship between PIL and reduced risk of premature mortality in older 
adults after controlling for depressive symptoms (Boyle et al., 2009).  
Life Rating Scale. The Life Rating Scale (LRS) is a single item measure in which 
an individual is asked to rate QOL on a 5-point scale. This measure reflects individuals’ 
self-assessed QOL. A rating of 1 is “uncomfortable” and reflects the lowest QOL, a 
rating of 2 is “dissatisfied”, a rating of 3 is “content”, a rating of 4 is “happy”, and a 
rating of 5 is “joyous” and reflects the highest QOL (unpublished scale, ALS Patient 
Profile Project). 
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ALS Severity Scale. The ALS Severity Scale (ALSS) is used to rate functional 
impairment in patients with ALS (Hillel et al., 1989). The patient’s functionality is rated 
on four domains including the ability to speak or swallow and the movement of upper 
extremities and lower extremities (i.e., patient disease severity). A total score is 
calculated by adding the score on the four domains. Total severity ratings range from 2, 
indicating complete loss of function, to 40, indicating completely intact function. Total 
severity scores of 2-16 reflect severe ALS severity, scores of 17-28 reflect moderate 
severity, and scores of 29-39 reflect mild ALS severity at the time of assessment. Inter-
rater reliability is estimated at .95 (Hillel et. al, 1989). Within growth models, ALSS was 
linearly transformed (40-score) so higher scores reflect greater disease severity. 
Data Analysis 
Multilevel modeling (MLM) using PROC MIXED with maximum likelihood 
estimation in SAS 9.4 was utilized to evaluate the hypothesized trajectories and 
relationships. Separate analyses were run for patients and caregivers, except for dyadic 
analyses. MLM can accommodate repeated measures and nested data, including dyadic 
relationships, and allows for the use of all data points available (Singer & Willett, 2003). 
This made MLM well suited for this data set in which the number of and time between 
assessments varied by participant.  
The first set of hypotheses (i.e., 1a and 2a) involved the variance structure of PIL 
and QOL without regard to time. To examine whether variance in PIL and QOL was due 
to differences between individuals or changes within individuals, unconditional means 
models were applied. This type of model evaluates total variation of a measure without 
predictors, producing intraclass correlation coefficients (ICC). Unconditional means 
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models also provide an indication of whether a significant amount of within-individual 
change exists. When within-individual variance was non-zero, linear growth models were 
applied to explain contributing factors of within-individual change.  
The following equation represents an unconditional means model. PILij 
corresponds to PIL at wave i for person j. An individual’s average PIL score corresponds 
to β0j, and eij is the residual associated with wave i. The individual’s average score, β0j, 
can be expressed in terms of the prototypic intercept or grand mean of the sample, γ00, 
and the individual β0j’s residual or deviation from the grand mean, ζ0j. The random term, 
ζ0j, in Level 2 of this model allowed individuals’ average PIL to differ from the sample 
mean.  
Unconditional means model: 
Level 1  PILij= β0j + eij 
Level 2  β0j = γ00 + ζ0j 
The second set of hypotheses (i.e., 1b, 2b, and 2c) tested the relationship between 
time and well-being (i.e., PIL and QOL). To examine whether time explained variance in 
PIL and QOL, linear growth models were applied. These models predict well-being from 
time. The goal of these analyses was to shed light on whether change in well-being was 
structured with time and how much of the variance was explained by the passage of time. 
Time since patient diagnosis was hypothesized as the best functional form for 
time; however, additional centering options were examined for best model fit. Three 
systematic ways of modeling the change in PIL and QOL over time were explored. The 
first two methods involved centering time at date of patient diagnosis and date of death. 
Data collected over the course of the study varied in the length of time the patient had 
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lived with the disease, their proximity to death, and disease stage. Therefore, to better 
interpret how these measures of well-being change around critical points of the disease, 
time was centered allowing for these trajectory comparisons.  
The following equation represents a linear growth model. Level 1 of these models 
introduces time (centered at patient diagnosis date or death date) as a predictor of change 
in the outcome (PIL or QOL). PILij corresponds to PIL for wave i, for person j. β0j 
corresponds to an individual’s PIL at the centered date (i.e., diagnosis date or death date). 
β1j is the coefficient for the time since patient diagnosis (Tdiagnosis) or time to death (Tdeath) 
and eij is the residual. Random effects were tested for the slope, which evaluated 
significant individual differences in change over time (β1j). These analyses shed light on 
whether the passage of time since patient diagnosis affects change in well-being 
differently for different people.  
Linear growth model: 
Level 1  PILij = β0j  + β1j  (Tdiagnosis) + eij 
Level 2  β0j = γ00 + eij 
β1j = γ10 + [ζ0j] 
The third model accounted for both when individuals entered the study (i.e., 
nearness to diagnosis or death) and how individuals changed across time in the study. 
These models separated out individuals' characteristics at baseline and their change over 
time within the study. To examine between-individual differences, an interaction term 
was also included that allowed individual trajectories to differ based on patient baseline 
characteristics (i.e., time from patient diagnosis at initial visit and time to death at initial 
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visit). Therefore, these “between-within” models evaluated both between-individual and 
within-individual differences in PIL and QOL.  
The following equation represents a between-within model predicting PIL change 
over time within the study from time since patient diagnosis at initial study visit. The 
passage of time in the study (TW), within people is at Level 1 and time since patient 
diagnosis at initial study visit (TBdiagnosis), between people is at Level 2. An interaction 
was tested between these effects (TW*Bdiagnosis). At Level 1, β1j is the coefficient for time 
in the study, or the passage of time during study participation. β0j represents the intercept 
centered at patient diagnosis date (or death). γ11 represents the coefficient for the cross-
level interaction; passage of time in the study moderated by time since diagnosis at 
baseline.  
Between-within model: 
Level 1  PILij = β0j + β1j  (TW) + eij 
Level 2  β0j = γ00 + γ01 (TBdiagnosis) + eij 
   β1j = γ10 + γ11 (TW*Bdiagnosis) + [ζ1j ] 
ALS is a progressive disease; therefore it is possible that time acts as a proxy for 
disease progression. However, unlike time, functional rating scales for disease severity in 
patients with ALS are not necessarily linear. Some evidence suggests that disease 
progression in ALS is curvilinear (Gordon et al., 2010). In addition, as patients receive 
multidisciplinary care and adaptive equipment, disease progression may slow for a period 
of time. It is possible that the pattern of variability in disease severity may capture change 
that is not adequately captured by linear time. Therefore, disease severity was examined 
in its relationship to time predictors and an alternative growth model including disease 
 18 
severity was explored. First, a model was constructed predicting ALSS scores from time 
to evaluate convergence of time with disease severity. Next, models predicting PIL and 
QOL from disease severity were examined. Third, disease severity was added to linear 
growth models of time to examine whether disease severity explained variance in well-
being (PIL and QOL) above and beyond change due to time. This information was used 
to determine if the pattern of disease progression was similar to time, whether disease 
severity predicts well-being, and if disease severity accounts for variability in well-being 
that time does not.  
Criteria for evaluating the best model among the aforementioned methods 
included both fit statistics and explained variance. First, models were compared in terms 
of lowest -2 log likelihood (-2LL) and Akaike’s information criterion (AIC); lower 
numbers indicate better quality of model fit. Second, the Level 1 pseudo-R2 was 
examined for the amount of within-individual variance each model explained for patients 
and caregivers. The model most convergent on these criteria for patients and caregivers 
was selected for further analysis. 
Lastly, the third set of hypotheses (i.e., 3a and 3b) involved whether a relationship 
exists in PIL or QOL within the dyad (i.e., patients and their respective caregivers). The 
basic structure of these models was the unconditional means model and the linear growth 
model described above. In addition, these models utilized dummy coding for dyad 
members and a covariance matrix to evaluate patient and caregiver intercepts and slopes 
for interrelation within and across dyads. 
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Table 1 
Sample Demographics, Disease Characteristics, and Baseline Scores 
 Patients Caregivers 
Demographics 
Age at enrollment in years 61 (11) 57 (14) 
Male 66.2% 28.2% 
Female 33.8% 71.8% 
White 94.6% 93.6% 
African American 3.6% 4.5% 
Hispanic 0.8% --- 
Asian --- 0.9% 
Native American 0.8% 0.9% 
Spouse to patient --- 85.5%  
Family member to patient --- 14.5%  
Disease characteristics 
Age at diagnosis in years 57 (12) --- 
Disease duration years (diagnosis to death) 7 (8) --- 
Limb onset 82.3% --- 
Bulbar onset 16.1% --- 
Other onset 1.6% --- 
Respirator use at enrollment 12.3% --- 
Feeding tube at enrollment 10% --- 
Years since diagnosis at enrollment 4.02 (4.07) --- 
Years to death at enrollment 3.88 (5.00) --- 
Baseline scores 
Baseline PIL 106.02 (16.88) 111.09 (15.97) 
Baseline QOL 2.68 (1.03) 2.70 (.98) 
Baseline ALSS 24.32 (8.55) --- 
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Chapter Three: Results 
Preliminary Analyses 
Preliminary analyses were conducted to examine the data distribution and inspect 
the independent and dependent variables in respect to normality and adherence to 
statistical assumptions of MLM. Tests for normality revealed that time to patient death 
(expressed in yearly quarters) had moderate skewness of -1.29 (SE = .099). The other 
independent and dependent variables exhibited normal distribution characteristics. This 
study aimed to better understand the trajectory of PIL and QOL over the course of the 
disease. Enrollment was widely inclusive to patients at different disease stages. 
Therefore, observed data varied across a range of time from critical points (diagnosis and 
death). Wide variation was expected among these time points. For this reason artificially 
transforming this variability was avoided and no correctional action was taken for time to 
patient death.  
Furthermore, the sample included patients using respirators and feeding tubes at 
baseline. The decision to use a respirator long-term may accompany a process of 
adaptation and coping prior to patient death. Two respirator status covariates were 
applied separately within each model to ensure that respirator status did not impact the 
pattern of results. The first covariate included was dichotomously coded for any 
respirator use at each time point within the study. The second covariate included was 
dichotomously coded for respirator dependence (i.e., 20-24 hour use per day) at each time 
point within the study. Neither covariate resulted in substantive effects on the models. 
Therefore, the models presented below did not include respirator status covariates.  
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Correlations among dependent variables and sample descriptives are illustrated in 
Table 2. A strong correlation was observed for average PIL and QOL collapsed across all 
subjects and time points (r = .60, p < .01). However, within-person correlations revealed 
a small to medium relationship between PIL and QOL for patients (r = .20, p < .01) and 
caregivers (r = .35, p < .01), suggestive of discriminant validity for PIL and QOL despite 
some overlap between these variables. 
Variance Structure of PIL and QOL in Patients with ALS and their Caregivers 
There were significant differences in PIL and QOL both between and within 
individuals (Model 1, Tables 3 & 4; both p < .001). The intercepts within Model 1 
represent the sample average PIL scores, 103.61 for patients and 109.52 for caregivers. 
These scores fell within an “indecisive” level of PIL (scores 92-112). The proportion of 
total variance in PIL attributed to stable individual differences was 74% for patients and 
76% for caregivers. The majority of the variance in PIL was due to differences between 
individuals, reflecting substantial stability over time. The QOL intercepts revealed that 
the sample average scores, 2.62 for patients and 2.65 for caregivers, fell between 
“content” and “dissatisfied” ratings. Variance in QOL attributed to stable individual 
differences was lower than that for PIL: 60% for patients and 55% for caregivers. 
Therefore, self-assessed QOL exhibited greater within-person variability than PIL, 
consistent with previous research examining existential QOL (Roach et al., 2009). 
Although the majority of the variance in PIL was due to stable between-individual 
differences, this model also suggested the existence of a significant amount of within-
individual change in PIL. Therefore a linear growth model was warranted to assess the 
predictors of within-individual change for PIL and QOL. 
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Patient and Caregiver PIL and QOL Trajectories from Diagnosis Date 
Analyses examining time from diagnosis and time to death as predictors of PIL 
and QOL revealed poor model fit. Although unconditional means models indicated a 
significant amount of within-individual variance to be explained, when time from 
diagnosis and time to death were added, residual variance increased rather than 
decreased. However, the third model for time, including an interaction accounting for 
individual differences in nearness to diagnosis and death at study enrollment and the 
passage of time in the study, produced good model fit. Therefore, individual differences 
in point of study entry from diagnosis and to death within the observed data impeded the 
fit of the first two models. Due to poor model fit and in the interest of parsimony, only 
the between-within models of time are presented. 
Separate between-within models for patients and caregivers indicated length of 
time since diagnosis at study enrollment did not have a significant effect on differences in 
PIL among patients or among caregivers. Patient and caregiver PIL decreased 
significantly and systematically with the passage of time in the study. However, the 
between-within interaction term revealed that length of time from diagnosis at study 
enrollment moderated change in PIL for patients and caregivers, such that study 
enrollment closer to patient diagnosis date was associated with a faster decrease in PIL 
(Model 2a, Table 3). Those who enrolled in the study further from patient diagnosis date 
experienced a slower rate of decline, and in some cases stability (Figures 1 & 2). Model 
2a accounted for similar amounts of variance in PIL among patients (within-person: 7%, 
between-person: 1%) and caregivers (within-person: 6%, between-person: 2%). 
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QOL in patients and caregivers exhibited different patterns. Length of time since 
diagnosis at study enrollment did not have a significant effect on differences in QOL 
among patients. However, caregivers who enrolled in the study closer to the patient 
diagnosis date had significantly lower QOL. With time centered at diagnosis, only patient 
QOL decreased significantly and systematically with the passage of time in the study; 
caregiver QOL did not. Caregiver QOL trajectory was significantly moderated by length 
of time from patient diagnosis at study enrollment (Model 2a, Table 4). Though not 
statistically significant, patients who enrolled in the study closer to their diagnosis date 
also appear to have a somewhat faster decrease in QOL (Figures 3 & 4). Model 2a 
accounted for more variance in QOL among patients (within-person: 2%, between-
person: 6%) than caregivers (within-person: 1%, between-person: 1%). Therefore, time 
since diagnosis and the passage of time impacted within-individual change in PIL to a 
greater degree than QOL. 
Patient and Caregiver PIL and QOL Trajectories Approaching Patient Death 
Parallel growth models centered at date of death revealed a trend in which 
patients who enrolled in the study closer to their date of death had significantly lower 
PIL. For caregivers, nearness to patient death at study enrollment did not have a 
significant effect on differences in PIL. Patient and caregiver PIL decreased significantly 
and systematically with the passage of time in the study. Nearness to patient death at 
study enrollment moderated change in PIL for patients and caregivers, such that study 
enrollment closer to patient death was associated with a faster decrease in PIL. (Model 
2b, Table 3, Figures 5 & 6). Model 2b accounted for similar amounts of variance in PIL 
among patients (within-person: 6%, between-person: 5%) and caregivers (within-person: 
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6%, between-person: 3%). Models centered at diagnosis and death (i.e. 2a & 2b) 
accounted for similar portions of within-individual change for PIL. 
Patient and caregiver QOL trajectories centered at patient death were less 
congruent. Patients who enrolled in the study closer to their date of death had 
significantly lower QOL. For caregivers, nearness to patient death at study enrollment did 
not have a significant effect on differences in QOL. Patient and caregiver QOL decreased 
significantly and systematically with the passage of time in the study. The between-
within interaction term revealed a tendency towards a faster decrease in QOL for patients 
who enrolled in the study closer to their date of death, although statistical significance 
was not reached. For caregivers, nearness to patient death at study enrollment moderated 
change in QOL, such that study enrollment closer to patient death was associated with a 
faster decrease in QOL (Model 2b, Table 4, Figure 8). Model 2b accounted for similar 
portions of variance in QOL among patients (within-person: 1%, between-person: 7%) 
and caregivers (within-person: 2%, between-person: 6%). Time to death explained 
greater between-individual differences than within-individual change in QOL. 
The Impact of Disease Severity on Patient and Caregiver PIL and QOL Trajectories  
Patient disease severity was also evaluated as a predictor of QOL. Preliminary 
models examined convergence between time and disease progression. Time since 
diagnosis at enrollment and the passage of time in the study explained 63% of the within-
individual variance in disease progression (pseudo-R2 = .63). No additional between-
individual variance was accounted for. Within this model, time since diagnosis at study 
enrollment did not have a significant relationship to overall patient disease severity (p = 
.11). However, time within the study significantly predicted increases in disease severity 
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(p < .001). Additionally, the interaction of time from patient diagnosis with the passage 
of time in the study also significantly predicted disease severity, such that patients who 
enrolled in the study closer to their diagnosis date had a faster rate of disease progression 
over time, (p < .001). 
The model with time centered at date of death revealed that time to death at study 
enrollment and the passage of time explained 54% of the within-individual variance in 
disease progression (pseudo-R2 = .54). No additional between-individual variance was 
accounted for. Time to patient death at study enrollment significantly predicted overall 
patient disease severity. Patients who enrolled in the study closer to their date of death 
had significantly greater disease severity (p = .01). Time within the study again 
significantly predicted increases in disease severity (p < .001). Additionally, the 
interaction of time to patient death with time in the study significantly predicted disease 
severity (p < .001). Patients who enrolled in the study closer to their date of death had a 
slower rate of disease progression across time within the study.  
Most temporal variables were significantly related to disease severity. These 
models of time explained over half of the variance in disease severity. However, both of 
these models indicated a significant amount of residual variance in disease severity not 
explained by time (both p < .001). Therefore, an additional model predicting PIL and 
QOL from decreases in functional ratings on the ALSS scale (i.e., disease severity) was 
applied. 
Growth models indicated that increases in patient disease severity significantly 
predicted decreases in both patient and caregiver PIL (both p < 0.01). There were 
significant individual differences in the effect of disease severity on PIL (i.e., a random 
 26 
effect) among patients but not caregivers (Model 3, Table 3). Figure 9 illustrates the 
trajectory of change in PIL with disease severity. Model 3 accounted for more within-
individual variance in PIL in patients (within-person: 15%) and caregivers (within-
person: 8%) than the previously tested time models. No additional between-person 
variance in PIL was explained by disease severity beyond the unconditional models. 
Patient disease severity also significantly predicted decreases in patient and 
caregiver QOL (both p < 0.01). However, there were individual differences in the effect 
of disease severity on QOL for caregivers but not patients, opposite to that of PIL (Model 
3, Table 4). Figure 10 illustrates the trajectory of change in QOL with disease severity. 
Model 3 also accounted for more within-individual variance in QOL in patients (within-
person: 3%, between-person: 1%) and caregivers (within-person: 9%, between-person: 
4%) than prior models. Results indicated that for patients and caregivers, the greatest 
amount of within-individual variance in QOL was explained by patient disease severity, 
although to a greater extent for caregivers.  
Next, disease severity was added to between-within models of time. In patients 
and caregivers with time centered at diagnosis, results revealed that disease severity 
accounted for 2% additional within-person and between-person variance in PIL, above 
and beyond change due to time. For patients with time centered at death, 2% additional 
within-person variance in PIL was accounted for by disease severity. No additional 
between-person variance in QOL was accounted for in patients. For caregivers, 2% 
additional within-person variance and 0.9% additional between-person variance in PIL 
were accounted for by disease severity.  
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Disease severity also explained additional variance in QOL beyond between-
within models of time. In patients with time centered at diagnosis, disease severity 
accounted for 1% additional within-person variance and 2% additional between-person 
variance in QOL, above and beyond time. In caregivers with time centered at patient 
diagnosis, disease severity accounted for 1% additional within-person variance and 6% 
additional between-person variance in QOL. In patients with time centered at death, 
disease severity accounted for an additional 2% of within-person variance in QOL. No 
additional between-person variance was accounted for by disease severity in patients. In 
caregivers, disease severity accounted for 1% additional within-person variance and 3% 
additional between-person variance in QOL above and beyond time. Therefore time and 
disease severity both predicted decreases in PIL and QOL, but disease severity accounted 
for slightly more within-individual variance above and beyond time. 
Growth Model Comparison 
In order to select the best model for dyadic analyses, several comparisons were 
made. First, fit statistics for Models 1-4 were compared. The models predicting PIL and 
QOL from disease severity resulted in the smallest 2-log likelihood and AIC for both 
patients and caregivers, reflecting best model fit. However, for caregiver PIL and QOL, 
Model 2b evaluating time to death and time within the study produced comparable 
decreases in the -2LL. For patient PIL, Model 2a evaluating time since diagnosis and 
time within the study also produced a decrease in the -2LL similar to Model 3. 
Next, these models were compared in regard to the amount of within-individual 
explained variance. Model 3 including disease severity as a predictor of PIL explained 
the greatest amount of within-person variance in both patients (15%) and caregivers 
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(8%). The same was found for QOL; Model 3 explained the greatest amount of within-
person variance for patients (3%) and caregivers (9%). These criteria consistently favored 
disease severity as the best predictor of change in PIL and QOL, and therefore Model 3 
was selected as the best model for the dyadic analyses. 
The Dyadic Relationship between Patient and Caregiver Mean and Intraindividual 
Variability of PIL and QOL 
Dyadic models revealed that patient and caregiver dyad mean PIL did not 
significantly covary (between-dyad covariance = 21.97, SE = 25.02, p = .38, r = .10). 
However, PIL did significantly fluctuate together within the dyad; a small within-dyad 
correlation was observed (within-dyad covariance = 14.97, SE = 4.39, p < .001, r = .19). 
In contrast, patient and caregiver mean QOL significantly covaried; a moderate 
between-dyad correlation was observed (between-dyad covariance = .18, SE = .07, p = 
.01, r = .31). This reflects that the average QOL of the dyad was similar, whereas average 
PIL was not. QOL did not change together over time within the dyad (within-dyad 
covariance = .02, SE = .02, p = .32, r = .05).  
Next, the best-fit growth model, disease severity, was applied as a predictor of 
dyad covariance. Linear dyadic models revealed that within-dyad PIL covariance was 
significantly predicted by patient disease severity. Disease severity accounted for 44% of 
the PIL within-dyad covariance (pseudo-R2 = .44). For QOL, disease severity did not 
significantly predict between-dyad QOL mean covariance (pseudo-R2 = .006). 
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Table 2 
Correlations among Dependent Variables and Descriptives 
Variable 
1 2 3 4 5 
1. Caregiver status -.39** -.17** .15* .03 
2. Male Gender .07 .03 -.005 
3. Age at enrollment -.07 -.08 
4. Average PIL .60** 
5. Average QOL
a. Patient Within-person PIL with QOL .20** 
b. Patient Between-person PIL with QOL .77** 
c. Caregiver Within-person PIL with QOL .35** 
d. Caregiver Between-person PIL with QOL .66** 
Note: Correlations 1-5 are Pearson product-moment correlation coefficients. 
Correlations a-d were obtained through MLM estimates. 
*p < 0.05; **p < 0.01
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Table 3 
Effects of Time and Disease Progression on PIL 
Parameter Patients Caregivers 
Model 1 Model 2a Model 2b Model 3 Model 1 Model 2a Model 2b Model 3 
Fixed effects 
Intercept 103.62 
(1.55) 
104.84 
(2.21) 
103.42 
(2.00) 
114.14 
(2.76) 
109.52 
(1.40) 
109.37 
(1.98) 
109.38 
(1.81) 
120.00 
(2.35) 
TBdiagnosis .05 
(.10) 
.10 
(.09) 
TBdeath -.14 
(.08) 
-.11 
(.07) 
TW -1.95** 
(.34) 
-1.75** 
(.35) 
-1.48** 
(.32) 
-1.60** 
(.33) 
Disease progression -.62** 
(.14) 
-.59** 
(.11) 
Interactions 
TW*Bdiagnosis .05** 
(.01) 
.04** 
(.01) 
TW*Bdeath -.03* 
(.01) 
-.03** 
(.009) 
Random effects 
Intercept variance 
(between-person) 
278.42 
(38.33) 
274.84 
(37.68) 
264.83 
(36.53) 
350.41 
(101.01) 
188.41 
(28.14) 
184.48 
(27.54) 
182.18 
(27.20) 
189.91 
(28.26) 
Disease progression 
slope variance 
.59 
(.28) 
Intercept slope 
covariance 
-7.70 
(4.96) 
Residual variance 
(within-people) 
94.22 
(6.18) 
87.96 
(5.77) 
88.95 
(5.83) 
80.50 
(5.59) 
59.13 
(4.43) 
55.59 
(4.17) 
55.30 
(4.14) 
54.44 
(4.08) 
ICC .74 .76 
Variance components 
-2 log likelihood 4710.7 4676.4** 4677.4** 4662.4** 3458.6 3434.1** 3430.9** 3429.2** 
AIC 4716.7 4688.4 4689.4 4674.4 3464.6 3446.1 3442.9 3437.3 
Level 1 pseudo-R2 
(within-person) 
.07 .06 .15 .06 .06 .08 
Level 2 pseudo-R2 
(between-person) 
.01 .05 -- .02 .03 -- 
Note: ICC, intraclass correlation coefficient, AIC, Akaike’s information criterion. *p < 0.05; **p < 0.01 
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Table 4 
Effects of Time and Disease Progression on QOL 
Parameter Patients Caregivers 
Model 1 Model 2a Model 2b Model 3 Model 1 Model 2a Model 2b Model 3 
Fixed effects 
Intercept 2.62 
(.08) 
2.54 
(.12) 
2.54 
(.11) 
3.12 
(.15) 
2.65 
(.08) 
2.50 
(.11) 
2.57 
(.11) 
3.11 
(.18) 
TBdiagnosis .008 
(.005) 
.01* 
(.005) 
TBdeath -.008* 
(.004) 
-.007 
(.004) 
TW -.08** 
(.02) 
-.06** 
(.02) 
-.05 
(.03) 
-.06* 
(.03) 
Disease progression -.03** 
(.007) 
-.02** 
(.009) 
Interactions 
TW*Bdiagnosis .002** 
(.0009) 
.002 
(.001) 
TW*Bdeath -.001 
(.0007) 
-.002* 
(.0008) 
Random effects 
Intercept variance 
(between-person) 
.68 
(.10) 
.64 
(.10) 
.63 
(.10) 
.67 
(.10) 
.52 
(.09) 
.47 
(.08) 
.49 
(.09) 
1.09 
(.42) 
Disease progression 
slope variance 
.003 
(.001) 
Intercept slope 
covariance 
-.04 
(.02) 
Residual variance 
(within-people) 
.45 
(.03) 
.44 
(.03) 
.44 
(.03) 
.43 
(.03) 
.42 
(.03) 
.41 
(.03) 
.41 
(.03) 
.38 
(.03) 
ICC .60 .55 
Variance components 
-2 log likelihood 1467.9 1451.6** 1453.8** 1451.5** 1093.6 1080.9* 1079.8** 1075.7** 
AIC 1473.9 1463.6 1465.8 1459.5 1099.6 1092.9 1091.8 1087.7 
Level 1 pseudo-R2 
(within-person) 
.02 .01 .03 .01 .02 .09 
Level 2 pseudo-R2 
(between-person) 
.06 .07 .01 .01 .06 .04 
Note: ICC, intraclass correlation coefficient, AIC, Akaike’s information criterion. *p < 0.05; **p < 0.01 
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Figure 1 
Model 2a: Effects of Time from Diagnosis and Time within the study on Patient PIL  
 
Figure 2 
Model 2a: Effects of Time from Diagnosis and Time within the study on Caregiver PIL  
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Figure 3 
Model 2a: Effects of Time from Diagnosis and Time within the study on Patient QOL
 
Figure 4 
Model 2a: Effects of Time from Diagnosis and Time within the study on Caregiver QOL
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Figure 5 
Model 2b: Effects of Time to Death and Time within the study on Patient PIL
 
Figure 6 
Model 2b: Effects of Time to Death and Time within the study on Caregiver PIL
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Figure 7 
Model 2b: Effects of Time to Death and Time within the study on Patient QOL
 
Figure 8 
Model 2b: Effects of Time to Death and Time within the study on Caregiver QOL
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Figure 9 
Model 3: Effects of Disease Progression on PIL 
 
 
Figure 10 
Model 3: Effects of Disease Progression on QOL 
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Chapter Four: Discussion 
The aims of the current research were to evaluate the variance structure, 
trajectory, and dyadic coupling of PIL and QOL in patients with ALS and their 
caregivers. The present study revealed that PIL was generally stable, whereas QOL 
fluctuated more widely within patients with ALS and their caregivers. Additionally, PIL 
within the dyad changed together over time, suggesting that change in PIL for patients 
was reflected in their caregivers and vice versa. This work provides evidence to suggest 
that, in patients with ALS and their caregivers, PIL may be an especially valuable 
psychological resource. However, critical periods exist for PIL and QOL trajectories in 
patients and caregivers.  
Variance Structure of PIL and QOL  
In line with hypotheses, PIL exhibited a variance structure primarily consisting of 
stable between-individual differences opposed to within-individual fluctuations. Similar 
to previous research, the variance structure of QOL exhibited greater within-person 
fluctuation than existential well-being (i.e., PIL) in both patients with ALS and caregivers 
(Roach et al., 2009). In contrast, the variance structure of the single-item QOL measure in 
the current study more closely resembled the variance structure of the total QOL measure 
in the previous study rather than the single-item component. In the current study, patients 
and caregivers exhibited similar proportions of stability and variance among the PIL and 
QOL measures, suggesting that the nature of well-being was similar for patients and 
caregivers. PIL was more stable than QOL and therefore may represent a potential 
psychological resource for both patients and caregivers across the course of ALS.  
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Trajectory of PIL and QOL  
Contrary to hypotheses, results revealed that both patient and caregiver PIL and 
QOL significantly decreased with disease severity and time. However, PIL and QOL 
trajectories differed based on proximity to critical points in the disease, diagnosis and 
death. Over the 18-month study period, individuals who enrolled closest to diagnosis and 
closest to death both showed the fastest decrease in PIL, whereas individuals enrolled in 
the middle phase of the disease, furthest from diagnosis and death, showed less decline in 
PIL. For QOL, the same moderation pattern emerged, though some results were not 
statistically significant. These findings highlight the complexity of modeling change in 
PIL and QOL in patients with ALS and their caregivers. It appears that phases of 
adjustment and adaptation occur for well-being in patients with ALS and their caregivers 
at different stages of the disease. At the middle stage of the disease, patients and 
caregivers may adapt, and PIL and QOL stabilize. It has been suggested that changes in 
one’s expectations and response shift may contribute to stability in QOL (Cupp et al., 
2011; Zamietra, 2012). However, the current results also suggest that PIL and QOL are 
not stable at all stages of the disease. Patients and caregivers appear to be vulnerable to 
losses in PIL and QOL during critical periods, following diagnosis and approaching end 
of life. These findings suggest patients with ALS and their caregivers need increased 
support especially at diagnosis, when approaching death, and in periods of rapid physical 
decline.  
Few previous studies have examined meaning and purpose in patients with ALS 
in relation to time or disease severity. Current results are consistent with cross-sectional 
research reporting that disease severity is associated with lower patient satisfaction with 
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meaning in life (Fegg et al., 2010). QOL has received greater attention in the literature, 
though results have been mixed. A number of studies have reported that general and self-
assessed QOL do not have significant relationships to time or disease severity in patients 
with ALS (Neudert, Wasner, & Borasio, 2004; Roach et al., 2009; Robbins et al., 2001; 
Simmons et al., 2000). Other studies have reported a significant relationship between 
patient general QOL and disease severity but not time (Rabkin et al., 2000), or an 
increase in general QOL over time (Gauthier et al., 2007). For caregivers, decreased 
general QOL over time has been reported (Roach et al., 2009). However, other research 
found no relationship between caregiver general QOL and patient disease severity 
(Gauthier et al., 2007). The current results indicate patient and caregiver self-assessed 
QOL decreased with disease severity and over time within the study.  
As mentioned, the extant literature on QOL trajectories in regard to disease 
severity and time is mixed, and somewhat discrepant from the reported findings. Several 
factors within the present study may underlie these differences, including the assessment 
period, data collection proximity to death, QOL measure utilized, and statistical method. 
The current study assessed QOL and PIL over an 18-month period, whereas the majority 
of previous research evaluated change in QOL over shorter periods of time. The current 
sample also included patients spanning different stages of the disease. Data collection 
took place in the patients’ homes, allowing individuals with more advanced illness to 
participate. Due to the challenges of studying ALS populations, the majority of previous 
research has been conducted in conjunction with multidisciplinary clinic visits. Patients at 
end-stage disease may be indirectly excluded due to the inability to travel. 
Multidisciplinary care has been shown to improve QOL (Van den Berg et al., 2005). Data 
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utilized in the current study was also collected prior to the Food and Drug 
Administration’s approval of modern selective serotonin re-uptake inhibitor 
antidepressants and Riluzole, the only pharmacological treatment for ALS. Therefore, the 
current sample represents a natural history of well-being in ALS. 
Differences in reports of stability in QOL in patients with ALS may also reflect 
the type of QOL measure utilized. A variety of QOL measures exist, including those 
assessing general QOL, health-related QOL, and self-assessed QOL. Health-related QOL 
produces different patterns over time and disease progression than other QOL indices 
(Neudert, Wasner, & Borasio, 2004; Robbins et al., 2001; Simmons et al., 2000). Yet, 
some research suggests general QOL and self-assessed QOL are highly correlated 
(Simmons et al., 2000). The discordance among different types of QOL measures in 
patients with ALS has been recognized as an important issue influenced by individual 
differences in patients’ perceptions (Hardiman, Hickey, & O'Donerty, 2004). The current 
study utilized a self-assessed single item measure of QOL. Findings therefore reflect 
individuals’ perceived QOL. Self-assessed QOL is focused on individual appraisal of the 
importance of one’s life conditions; an aspect infrequently included in general and health-
related QOL measures.  
The statistical method is another strength of the current research. MLM allows for 
the assessment of between-individual and within-individual variance, changes in 
trajectories over time, and individual differences in trajectories based on personal 
characteristics. Our research suggests change in PIL and QOL are dynamic processes 
impacted by disease stage at the time of assessment. Trajectories may appear stable if 
averaged, masking individual differences. 
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Dyadic Relationships of PIL and QOL  
Results of the current study suggest that patient and caregiver psychological 
health is intertwined. Relationships between PIL and QOL were evaluated at the level of 
the dyad (i.e., patients and their respective caregivers). In accordance with hypotheses, 
results indicate that average QOL between dyad members was significantly related. 
However, variance in QOL did not exhibit dyadic coupling over time in patients with 
ALS and their respective caregivers. Previous research supports the existence of a 
relationship between QOL in patients with ALS and caregivers. Relationships between 
self-assessed QOL (Trail, Nelson, Van, Appel, & Lai, 2003), general QOL (Gauthier et 
al., 2007; Rabkin et al., 2000), health-related QOL (Jenkinson et al., 2000), and 
existential QOL (Pagnini et al., 2011) have been reported among patient and caregiver 
groups. Contrary to the hypothesis, average PIL between dyad members was not 
significantly related. However, the current study provides novel evidence of dyadic 
coupling in PIL variance in patients with ALS and their caregivers. Dyadic relationships 
may reflect similar life conditions and a shared experience throughout the disease. These 
results provide support for conceptualizing ALS as a family disease, meaning that the 
patient and their family reciprocally impact one another through the disease experience 
(Gauthier et al., 2007). 
Limitations 
The present study has certain limitations. First, QOL was assessed with a single 
item patient-assessed measure that has not been previously validated. However, self-
assessed QOL has been recognized as an important aspect of well-being in patients with 
ALS (Hardiman, Hickey, & O'Donerty, 2004). Additionally, the study sample included 
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some individuals with exceptionally slow rates of disease progression. The average 
survival time (i.e., date of diagnosis to patient death) was longer than what is generally 
reported in the literature (Ringel et al., 1993). However, because the sample included 
individuals both near and far from critical periods (i.e., diagnosis and death), accounting 
for individual differences revealed important trajectory patterns. Finally, health care for 
patients with ALS has evolved since the study took place. Adaptive equipment has 
improved, which may impact patient autonomy and caregiver burden.  
Clinical and Research Implications 
The current results have implications for informing both intervention and research 
design. PIL was a stable psychological resource, though critical periods exist in which 
intervention may be needed most. Applying psychological interventions early on, 
following patient diagnosis, may mitigate future decline in well-being. PIL may be a 
source of resiliency that clinicians could explore to provide support to patients and 
caregivers. A number of therapies exist aimed to foster meaning and purpose in the 
terminally ill (see LeMay & Wilson, 2008 for a review). However, research examining 
the efficacy of such therapies is limited.  
Additional research is needed to examine how QOL and PIL affect end-of-life 
despair in patients with ALS as well as protective factors for PIL and QOL. Factors that 
impact PIL and QOL beyond time and disease progression should also be explored in 
patients with ALS and their caregivers. Coping styles may provide insight into individual 
differences in maintenance of well-being. Additionally, the extent to which patients and 
caregivers feel informed about the disease and empowered to make personal choices 
(e.g., treatment decision making and advance directives) may provide a sense of control, 
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which may impact well-being. Future research should also examine the factors that 
impact the disease experience in families of patients with ALS and to explore the 
direction of the relationship in well-being among patients and their respective caregivers.  
By nature, the ALS patient population is heterogeneous. Accordingly, challenges 
in statistical design and interpretation exist in studying well-being in patients with ALS. 
The current study provides evidence that individual baseline characteristics (i.e., time 
since diagnosis and time to death) impact the trajectory of PIL and self-assessed QOL in 
patients with ALS and their caregivers. Observational research and clinical trials using 
QOL as an outcome measure should consider taking into account individual differences 
such as disease severity, time since diagnosis, and time to death. Results also suggest that 
time and disease progression are not synonymous when it comes to changes in well-
being. Time and disease severity predicted well-being measures differently, although 
both had a negative impact. Therefore, examining well-being over time or in relation to 
disease severity in patients with ALS may produce different results. 
Conclusions 
The present study provides important new insight into the stability, variance 
structure, and dyadic coupling of PIL and self-assessed QOL in patients with ALS and 
their caregivers. PIL was markedly stable, yet QOL fluctuated more within individuals 
over the disease course, suggesting PIL is a potential psychological resource for patients 
and caregivers. However, periods of decline and stabilization were observed in PIL and 
QOL. Critical points in the disease (i.e., following diagnosis and approaching death) 
represent periods of decline in well-being trajectories. Disease severity was the strongest 
predictor of decreases in PIL and QOL, yet there were individual differences in the effect 
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of disease severity on PIL among patients and QOL among caregivers. Time and disease 
severity were more deleterious to PIL than to QOL. Factors other than disease severity 
likely play a larger role in QOL variability, such as coping styles or disease education. 
Finally, PIL and QOL in patients with ALS and their caregivers were interrelated. These 
findings build on the previous literature and highlight the dynamic and interwoven nature 
of well-being in patients with ALS and their caregivers, and provide avenues for future 
work investigating PIL as a resilience factor for individuals facing terminal illness and 
their caregivers.  
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Appendix: Abbreviations 
ALS- Amyotrophic Lateral Sclerosis 
ALSS- ALS Severity Scale 
ICC- Intraclass Correlation Coefficients 
IIV- Intraindividual Variability  
MLM- Multilevel Modeling  
PIL- Purpose in Life 
QOL- Quality of Life 
-2LL- -2 Log Likelihood 
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